Page last updated: 2024-11-02

oxybutynin and Acrania

oxybutynin has been researched along with Acrania in 4 studies

oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's3 (75.00)18.2507
2000's0 (0.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baek, M1
Kang, JY1
Jeong, J1
Kim, DK1
Kim, KM1
Painter, KA1
Vates, TS1
Bukowski, TP1
Fleming, P1
Freedman, AL1
Smith, CA1
Gonzalez, R1
Perlmutter, AD1
Amark, P1
Bussman, G1
Eksborg, S1
Kasabian, NG1
Bauer, SB1
Dyro, FM1
Colodny, AH1
Mandell, J1
Retik, AB1

Trials

1 trial available for oxybutynin and Acrania

ArticleYear
Follow-up of long-time treatment with intravesical oxybutynin for neurogenic bladder in children.
    European urology, 1998, Volume: 34, Issue:2

    Topics: Administration, Intravesical; Adolescent; Child; Child, Preschool; Cholinergic Antagonists; Female;

1998

Other Studies

3 other studies available for oxybutynin and Acrania

ArticleYear
Treatment outcomes according to neuropathic bladder sphincter dysfunction type after treatment of oxybutynin chloride in children with myelodysplasia.
    International urology and nephrology, 2013, Volume: 45, Issue:3

    Topics: Administration, Oral; Child, Preschool; Female; Follow-Up Studies; Humans; Male; Mandelic Acids; Mus

2013
Long-term intravesical oxybutynin chloride therapy in children with myelodysplasia.
    The Journal of urology, 1996, Volume: 156, Issue:4

    Topics: Administration, Intravesical; Adolescent; Child; Child, Preschool; Female; Humans; Infant; Male; Man

1996
The prophylactic value of clean intermittent catheterization and anticholinergic medication in newborns and infants with myelodysplasia at risk of developing urinary tract deterioration.
    American journal of diseases of children (1960), 1992, Volume: 146, Issue:7

    Topics: Boston; Combined Modality Therapy; Female; Follow-Up Studies; Hospitals, Pediatric; Humans; Hydronep

1992